Xsolla Set to Launch the Xsolla StarNest Academy and Incubator Program in Baku
9.12.2024 10:00:00 CET | Business Wire | Press release
Collaboration in Azerbaijan Aims to Build a Thriving Game Development Ecosystem and Empower Local Talent with New Programs Launching in 2025
Xsolla, a global video game commerce company, has announced a strategic partnership with StarNest and Azerbaijan’s Innovation and Digital Development Agency (IDDA) to establish the Xsolla StarNest Academy and Incubator Program. This transformative collaboration was unveiled at the region's largest gaming festival, Gamesummit Winter Edition 2024, in Baku, Azerbaijan.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209823866/en/
(Graphic: Xsolla)
Gamesummit Winter Edition 2024 spotlighted the growth of the gaming industry in Azerbaijan, featuring discussions on trends, global best practices, and presentations of locally developed games. At the festival, IDDA and Xsolla revealed plans to empower local developers, game designers, and studios with cutting-edge training, incubation and accelerator programs, and access to financial and technological resources. This partnership will redefine Azerbaijan's role in the global gaming industry while fostering local talent and innovation.
“This collaboration opens up extensive opportunities for implementing joint projects that will drive the development of Azerbaijan's gaming sector,” said Yevgeniya Bikmurzina, Head of IDDA's Innovation Ecosystem Department. “Azerbaijani game studios will have access to the tools and resources needed to make a mark in the global market.”
“This partnership represents a significant milestone for Xsolla as we collaborate with Azerbaijani leaders to unlock the region’s potential,” said Rytis Joseph Jan, SVP of Global Strategic Partnerships at Xsolla. “By combining our global expertise with the visionary leadership of our partners, we aim to empower the next generation of talent in Azerbaijan and drive meaningful innovation with global impact.”
Xsolla Incubator & Accelerator in Azerbaijan
The Xsolla Incubator and Accelerator will support Azerbaijan's game development community by providing tools, mentorship, and resources to turn ideas into successful projects. The Incubator will help early-stage developers refine concepts, gain technical expertise, and collaborate with international experts. The Accelerator will assist established studios in scaling their projects, offering access to funding, mentorship, and global industry connections. These programs aim to position Azerbaijan as a key player in the gaming industry, creating opportunities for local talent to succeed globally.
Xsolla StarNest Academy
The Xsolla StarNest Academy will provide 90 young individuals with specialized training in game development. Additionally, an incubation program will launch in 2025 to support local game studios, offering mentorship from international experts, access to financial resources, and opportunities to showcase games globally.
StarNest, an Azerbaijani telecommunications company, will lead efforts to secure a dedicated facility for the Academy, ensuring an environment conducive to growth and learning. IDDA will offer strategic oversight to align the initiative with Azerbaijan’s national goals for digital transformation.
Regional Headquarters
Xsolla is also exploring options to establish its regional headquarters for Central Asia in Baku to further support its commitment to the community and game developers in the region. Not only will it serve as a regional hub, but also a technology center for the leading edge development and support of its industry leading solutions.
With the Xsolla StarNest partnership this marks a new chapter for Azerbaijan’s gaming sector reflecting the shared vision to position the country as a regional game development and digital innovation leader.
This groundbreaking collaboration sets the stage for Azerbaijan to become a hub for gaming innovation and talent development. For more information, please visit: xsolla.blog/azerbaijan
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world.
For more information, visit xsolla.com
About the Innovation and Digital Development Agency (IDDA)
IDDA is an Azerbaijani government agency specializing in digital diplomacy and analytics, offering research, training, and consultancy to enhance the digital presence of institutions. It plays a pivotal role in shaping modern diplomatic strategies through digital tools and data analysis.
For more information, visit idda.az
About StarNest
StarNest is a leading Azerbaijani telecommunications company providing internet and networking solutions, including broadband services, corporate connectivity, and IT infrastructure support. StarNest is dedicated to enabling technological growth and digital transformation across Azerbaijan.
For more information, visit starnest.io
About GameSummit
GameSummit is a prominent organization in Azerbaijan focused on the development of the gaming industry. Through events like Gamesummit Winter and Summer Editions, it creates opportunities for local game studios, promotes innovation, and raises awareness about career prospects in gaming and esports.
For more information, visit gamesummit.ai
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209823866/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom